The public-private health care debate can seem a lot like a high school math class – there's a lot of noise, a few troublemakers and frequently a profound misunderstanding of the numbers. The Canadian Health Care Consensus Group (CHCCG), coordinated by AIMS, is adding a little clarity to the debate. This third paper published by the CHCCG shows how the data is often misunderstood and misused.
It’s a common cry – the increasing cost of prescription drugs is bankrupting the health care system. But is that actually the case? Advancements in technology have dramatically changed the face of medical care, and pharmaceuticals have been in the forefront. This paper published with the Canadian Health Care Consensus Group examines how today's drugs actually save the system money.
It is considered one of the most pressing issues in health care in Canada, the catastrophic gap in prescription drug coverage. On 16 May 2006, AIMS gathered the leading experts from across the country to discuss the topic. This is a summary of the "When Tea and Sympathy are not Enough" conference.
In this op/ed in The New York Post, AIMS president Brian Lee Crowley explains the real reason why brand-name drugs cost less in Canada. In reply to an ad campaign by the American Association of Retired Persons (AARP) urging Congress to legalize the importation of prescription drugs from Canada, Crowley explains the reason isn't simply price controls. And he tells Americans to be very careful what they wish for.
In this article that appeared in the Toronto Star, Brian Ferguson takes a look at a national pharmacare program and how to pay for it. It's a plan that could be used for more than just pharmaceuticals, if, as he suggests, Canadians acknowledge that while the government may pay the bills for health care, it uses our money to do so.
Catastrophic gap in prescription drug coverage: AIMS’ conference puts the issue on the national agenda
AIMS' conference on the catastrophic gap in prescription drug coverage in Atlantic Canada attracted patients, health care workers, pharmaceutical companies, insurance brokers, and government officials. Media across the country picked up this story with its clear message that AIMS set the stage to place the catastrophic gap in prescription drug coverage on the national agenda.